Pretransplant Evaluation and Liver Transplantation Outcome in PBC Patients

Figure 1

Risk assessment, treatment, and monitoring for PBC patients. early from advanced disease stage based on LSM by TE (LSM <10 kPa or LSM >10 kPa). both parameters normal vs. at least 1 parameter abnormal. absent or mild fibrosis vs. bridging fibrosis or cirrhosis. repeat TE every 2 years in early stage and every year for advanced disease.